Next-gen mRNA vaccine boosts immunity 28x in mice
New mRNA-nanoparticle vaccine boosts immune response 28x in mice, combining speed and efficacy.
Why it matters
- Combines mRNA speed with nanoparticle strength; could improve efficacy and safety.
By the numbers
- 28x higher immune response in mice vs. standard mRNA.
The big picture
- Potential for safer, more effective vaccines against multiple diseases.
What they're saying
- Experts optimistic about safety and efficacy.
- Lower doses may reduce side effects.
Caveats
- Tested only in mice so far.
- Human trials and funding needed.
What’s next
- Development for flu, Epstein-Barr vaccines.
- Further studies and trials planned.